Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

All Conditions

Mouth and Tooth Diseases

Ear, Nose, and Throat Diseases

Rare Diseases

Uterine Cervical Neoplasms

Uterine Cervical Dysplasia

Oropharyngeal Neoplasms

Uterine Cervical Diseases

Uterine Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Precancerous Conditions

Pharyngeal Neoplasms

Otorhinolaryngologic Neoplasms

Head and Neck Neoplasms

Pharyngeal Diseases

Stomatognathic Diseases

Otorhinolaryngologic Diseases

Cervical Intraepithelial Neoplasia

All Drugs and Chemicals

Vaccines

Women born in 1997, resident to Norway in 2009, vaccinated by the quadrivalent HPV vaccine.

Interventions:

* Self sample from vagina using Rover's Evalyn Brush
* Self sample from the oral cavity using COPAN's FloqSwab
* Questionnaire

Women born in 1997, resident to Norway in 2009, not vaccinated by the quadrivalent HPV vaccine

Interventions:

* Self sample from vagina using Rover's Evalyn Brush
* Self sample from the oral cavity using COPAN's FloqSwab
* Questionnaire

Self sample using The Rover's Evalyn Brush

Self sample from vagina

Self sample from the oral cavity

Questionnaire about vaccination status and sexual behaviour

Questionnaire

Espen Enerly, Dr Scient

Giske Ursin, Dr.Med

The overall aim of the study is to assess the effect of school-based Human Papillomavirus (HPV) vaccination by comparing type-specific HPV prevalence between vaccinated and non-vaccinated women born in 1997. Women born in 1997, residence to Norway in 2009 (the year of vaccine initiation of the 1997-cohort) are invited to participate in the study.

This cohort is amongst the first that was offered HPV vaccine in an organized vaccination programme globally. The women will be recruited through Facebook ads. The study will enable us to measure differences in the prevalence of HPV types in vagina and the mouth between vaccinated and non-vaccinated young women in Norway.

The womens vaccination status will be validated by linkage to the Norwegian Immunisation Registry (SYSVAK) and their residence status will be validated through linkage to the Norwegian Population Registry.

Self samples from vagina and the oral cavity

Impact of HPV Vaccine On The Prevalence Of HPV In Norway

Impact of HPV Vaccine On The Prevalence Of Human Papillomavirus In Mouth And Vagina In Norway

The differences in HPV types prevalence among vaccinees and non-vaccinees. HPV types will be assessed individually and combined.

University Hospital, Akershus

Oslo University Hospital

Dr Scient

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Impact of HPV Vaccine On The Prevalence Of HPV In Norway	NCT02934724	Cervical Intrae... Cervical Cancer Oropharyngeal C...	Self sample fro... Self sample fro... Questionnaire	18 Years - 20 Years	Oslo University Hospital
Impact of HPV Vaccine On The Prevalence Of HPV In Norway	NCT02934724	Cervical Intrae... Cervical Cancer Oropharyngeal C...	Self sample fro... Self sample fro... Questionnaire	18 Years - 20 Years	Oslo University Hospital

Spots Global Cancer Trial Database for self sample from the oral cavity